Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-25-000592
Filing Date
2025-10-01
Accepted
2025-10-01 16:06:19
Documents
1
Period of Report
2025-09-29

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 11492
  Complete submission text file 0001012975-25-000592.txt   15486
Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019 212-257-4410
Sessa Capital IM, L.P. (Reporting) CIK: 0001595849 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1214
Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 251364679

Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019 212-257-4410
Sessa Capital (Master), L.P. (Reporting) CIK: 0001618360 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 251364681

Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019 212.257.4410
Sessa Capital GP, LLC (Reporting) CIK: 0001618699 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 251364680

Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019 212.257.4410
Sessa Capital IM GP, LLC (Reporting) CIK: 0001618700 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 251364678

Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019
Business Address
Petry John (Reporting) CIK: 0001618702 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 251364677

Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)